About: Covid-19: current knowledge, disease potential, prevention and clinical advances

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Covid-19: current knowledge, disease potential, prevention and clinical advances Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Covid-19: current knowledge, disease potential, prevention and clinical advances
Creator	Biol, Turk Alam, Aftab Ali, Rafat Ishrat, Romana Siddiqui, Faizan
Source	Medline; PMC
abstract	The top priority of any nation is to lead the nation towards prosperity, progress, and economic growth, confronting several challenges and concerns arisen from global situations. The sudden outbreak of any disease defies the health care systems and economy of nations. COVID-19 is one of the viral diseases which broke out in Wuhan city of China in 2019. COVID-19 outbreak intermittently prevailed all over the world. It exposes the fragility of the established health care systems across the world in spite of comprising modern science and technology. Unfortunately, there is no chemotherapeutic agent in the regimen of antiviral drugs or no vaccine available to curb this infectious disease. As a consequence, this deadly infection has prevailed all over the world. The antiviral drugs used for viral diseases excluding COVID-19 infection are Ramdesvir, Favipiravir, and Ribavarin, and antimalarial agents (Chloroquine & Hydroxychloroquine) are being administered to the patients for redemption of this infection. Fortunately, these existing drugs have been found clinically active and are being used. In this review, we present the current scenario and status of epidemiology, diagnosis, treatment, vaccine development for COVID-19, and its impact on the socio-economic structure.
has issue date	2020-06-21(xsd:dateTime)
bibo:doi	10.3906/biy-2005-29
bibo:pmid	32595349
has license	cc-by
sha1sum (hex)	aa86b8d167b2b5889580a654e0b7d4b8484cc933
schema:url	https://doi.org/10.3906/biy-2005-29
resource representing a document's title	Covid-19: current knowledge, disease potential, prevention and clinical advances
has PubMed Central identifier	PMC7314501
has PubMed identifier	32595349
schema:publication	Turk J Biol
resource representing a document's body	covid:aa86b8d167b2b5889580a654e0b7d4b8484cc933#body_text
is schema:about of	named entity 'progress' named entity 'viral diseases' named entity 'disease' named entity 'Turkish' named entity 'CHALLENGES' named entity 'ITS' named entity 'ESTABLISHED' named entity 'CONCERNS' named entity 'health care systems' named entity 'viral diseases' named entity 'chemotherapeutic agent' named entity 'city' named entity 'current' named entity 'socio-economic structure' named entity 'health care systems' named entity 'antimalarial agents' named entity 'COVID-19' named entity 'China' named entity 'viral diseases' named entity 'Chloroquine' named entity 'COVID-19 outbreak' named entity 'vaccine' named entity 'health care systems' named entity 'vaccines' named entity 'Hydroxychloroquine' named entity 'vaccines' named entity 'quarantine' named entity 'contagious disease' named entity 'coronavirus' named entity 'SARS' named entity 'viral infections' named entity 'MERS-CoV' named entity 'host cell' named entity 'Bangladesh' named entity 'public health issue' named entity 'acute respiratory distress syndrome' named entity 'Iran' named entity 'disease transmission' named entity 'infection' named entity 'acute kidney injury' named entity 'Saudi Arabia' named entity 'fever' named entity 'Turkey' named entity 'severe pneumonia' named entity 'COVID' named entity 'glycoprotein' named entity 'RNA' named entity 'pneumonia' named entity 'malaria' named entity 'receptor binding domain' named entity 'corona virus' named entity 'RNA' named entity 'protein' named entity 'COVID' named entity 'RNA polymerase' named entity 'human beings' named entity 'genetic analysis' named entity 'asymptomatic patients' named entity 'older age' named entity 'Coronavirus' named entity 'Sofosbuvir' named entity 'Bangladesh' named entity 'COVID-19.' named entity 'preclinical' named entity 'COVID-19 outbreak' named entity 'Homologous recombination' named entity 'COVID' named entity '50 million' named entity 'France' named entity 'Chloroquine' named entity 'RNA-dependent RNA polymerase' named entity 'antiviral' named entity 'COVID' named entity 'bat' named entity 'dyspnea' named entity 'species barrier' named entity 'wet markets'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software